Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma
Authors:
Open Access
Abstract
BACKGROUND: The liver is the most frequent site of recurrence after curative resection in patients with colon carcinoma. For liver metastasis, a high response rate can be achieved with hepatic arterial infusion (HAI) chemotherapy. In the current study, the authors administered 5‐fluorouracil (5‐FU) as adjuvant chemotherapy by HAI to patients with colon carcinoma without liver metastases and studied its effects on recurrence in the liver and survival.METHODS: A total of 316 patients with preoperative Stage II or Stage III colon carcinoma (according to the 1997 revision of the International Union Against Cancer TNM staging system) were randomly assigned to receive surgery plus 3‐week continuous HAI of 5‐FU or surgery alone. There were 305 eligible patients, of whom the 119 patients assigned to the HAI arm actually received 5‐FU. The primary endpoint was disease‐free survival, whereas the secondary endpoints were overall survival and liver metastasis‐free survival. Analysis was by intent to treat.RESULTS: There were no significant differences noted in morbidity between the two treatment arms. During the follow‐up period (median, 59.0 months), the incidence of liver metastasis was significantly decreased in the HAI arm whereas there were no significant differences reported between the 2 arms with regard to the frequency of metastasis at other sites. In the HAI arm, the risk ratio for recurrence was 0.40 (95% confidence interval [95% CI], 0.24–0.64; P = 0.0002), the risk ratio for death was 0.37 (95% CI, 0.21–0.67; P = 0.0009), and the risk ratio for liver metastasis was 0.38 (95% CI, 0.22–0.66; P = 0.0005). These differences were found to be significant only for patients with Stage III disease. Toxicities were mild.CONCLUSIONS: A schedule of 3‐week HAI of 5‐FU given as adjuvant chemotherapy to patients with Stage III colon carcinoma appeared to contribute to a significant decrease in the frequency of liver metastases and was associated with an improved survival rate. Cancer 2004. © 2003 American Cancer Society.Keywords
This publication has 20 references indexed in Scilit:
- Combined-Modality Treatment for Resectable Metastatic Colorectal Carcinoma to the Liver: Surgical Resection of Hepatic Metastases in Combination With Continuous Infusion of Chemotherapy--An Intergroup StudyJournal of Clinical Oncology, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Prevention of Hepatic Artery Occlusion During Continuous Infusion of Fluorouracil Using LiposteroidAmerican Journal of Roentgenology, 2000
- Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal CancerNew England Journal of Medicine, 1999
- Reappraisal of Hepatic Arterial Infusion in the Treatment of Nonresectable Liver Metastases From Colorectal CancerJNCI: Journal of the National Cancer Institute, 1996
- Vascularization of small liver metastasesBritish Journal of Surgery, 1989
- Contact ultrasonography in the detection of liver metastases from colorectal cancer: An in vitro studyBritish Journal of Surgery, 1987
- Haematogenous metastastic patterns in colonic carcinoma: An analysis of 1541 necropsiesThe Journal of Pathology, 1986
- A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancerBritish Journal of Surgery, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958